Dr. Novie Sroa, MD

Dr. Sroa practices at Wise Clinical Care Associates in Bridgeport, Texas.

Dr. Sroa's NPI, 1467574343, was assigned on April 4, 2007. Dr. Sroa graduated from Ohio State College of Medicine in 2006. Dr. Sroa holds Texas license S0228.

Dr. Sroa's primary practice is Wise Clinical Care Associates, at 2202 Us-380, Bridgeport, TX 76426 in Wise County. The practice phone is (940) 683-2338.

Dr. Sroa's primary practice is Wise Clinical Care Associates in Bridgeport, Texas. The medical group on file is Wise Health Clinics. Dmand AI also links Dr. Sroa to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sroa practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Sroa's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sroa is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Sroa's licenses on file in 4 states: Texas, Michigan, Ohio and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Sroa treats.

CMS data shows 299 Medicare services from Dr. Sroa across 7 procedure codes in 2024, for 236 Medicare patients. Medicare paid $22,597 for them. Every service was in an office.

CMS counts 236 Medicare patients who saw Dr. Sroa in 2024. The largest group is 65 to 74, with 117 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sroa's median patient age at 56, with 56% women.

In 2024, Dr. Sroa wrote 421 Medicare Part D claims for 248 patients. 95% of them were for generic drugs. CMS names the drug for 333 of them, across 7 drugs with 11 or more claims each, at $11,549 in total drug cost. In 2023, CMS named 469 claims across 9 drugs.

Dr. Sroa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 61 procedures of skin biopsy by Dr. Sroa, more than 71% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Sroa in 2012. 2012 was the busiest year, with 2. The most frequent topics are Phenotype and Skin Neoplasms. Dr. Sroa has published most often in J Clin Aesthet Dermatol. Dr. Sroa's most frequent co-authors are Mark Allen Bechtel, DO, Thomas N. Helm, MD and Leonid Izikson, MD.

CMS Open Payments shows 158 general payments to Dr. Sroa from 24 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $495. It also lists 6 research payments totaling $881 in 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Sroa.

Dr. Sroa graduated from Ohio State College of Medicine in 2006. Dr. Sroa is a member of American College of Mohs Surgery.

Dr. Sroa is in network with 27 carriers, including Aetna, Excellus BlueCross BlueShield and Health Alliance Plan. PPO plans come from the most carriers, 18. Check the plan with the practice before a visit.